B. Riley Brokers Lift Earnings Estimates for Hyperfine, Inc. (NASDAQ:HYPR)

Hyperfine, Inc. (NASDAQ:HYPRFree Report) – Analysts at B. Riley boosted their Q3 2024 earnings per share estimates for Hyperfine in a research note issued to investors on Wednesday, May 15th. B. Riley analyst Y. Zhi now forecasts that the company will post earnings per share of ($0.13) for the quarter, up from their prior estimate of ($0.14). The consensus estimate for Hyperfine’s current full-year earnings is ($0.53) per share. B. Riley also issued estimates for Hyperfine’s Q4 2024 earnings at ($0.12) EPS and FY2024 earnings at ($0.53) EPS.

Separately, Wells Fargo & Company cut their price objective on Hyperfine from $2.10 to $1.60 and set an “equal weight” rating on the stock in a report on Friday, March 22nd.

Read Our Latest Research Report on Hyperfine

Hyperfine Stock Performance

Shares of HYPR stock opened at $0.89 on Friday. The stock’s 50-day simple moving average is $0.95 and its 200-day simple moving average is $1.06. The firm has a market capitalization of $64.26 million, a PE ratio of -1.51 and a beta of 0.82. Hyperfine has a fifty-two week low of $0.76 and a fifty-two week high of $3.28.

Hyperfine (NASDAQ:HYPRGet Free Report) last announced its quarterly earnings data on Thursday, March 21st. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.02. The business had revenue of $2.69 million for the quarter, compared to analyst estimates of $3.66 million. Hyperfine had a negative return on equity of 46.96% and a negative net margin of 358.59%.

Institutional Trading of Hyperfine

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp grew its holdings in Hyperfine by 304.3% during the third quarter. Bank of New York Mellon Corp now owns 219,582 shares of the company’s stock worth $450,000 after acquiring an additional 165,269 shares during the period. Journey Strategic Wealth LLC acquired a new stake in Hyperfine during the fourth quarter worth about $84,000. Signaturefd LLC acquired a new stake in Hyperfine during the third quarter worth about $102,000. EP Wealth Advisors LLC acquired a new stake in Hyperfine during the third quarter worth about $71,000. Finally, Knollwood Investment Advisory LLC acquired a new stake in Hyperfine during the third quarter worth about $41,000. 15.03% of the stock is owned by institutional investors and hedge funds.

About Hyperfine

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Featured Stories

Receive News & Ratings for Hyperfine Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Hyperfine and related companies with’s FREE daily email newsletter.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.

    Input this code: captcha